TRU - Truscreen

[whatsup]

Slowly but surely. Emphasis is on the word slowly, here

TruScreen strengthens its market presence in central and eastern Europe

As part of the rationalisation of its distributors network, Truscreen Limited
(NZX: TRU) ("the Company") is pleased to announce that it has appointed
prominent medical device distributor Aspironix, s.r.o (Aspironix) as its
exclusive distributor for Czech Republic, Slovakia, and Poland.

The territories of Czech Republic, Slovakia, and Poland, have a combined
cervical cancer addressable screening population of over 17.91 million women,
presenting a significant market opportunity for the Company.

Asprionix is a well-established specialised medical device distributor based
in Prague, with a rapidly growing turnover and increasing presence in central
and eastern Europe.

Together with Aspironix, the Company will develop a comprehensive market
access plan and have begun preliminary Key Opinion Leaders (KOL) engagement
for the region.

Truscreen CEO, Victoria Potarina, said "The distribution agreement with
Aspironix will enable us to significantly expand our distribution
capabilities in central and eastern Europe, bringing Truscreen's latest
real-time cervical cancer screening technology to the women of Czech
Republic, Slovakia and Poland.

The rationalisation of our distributor portfolio will see established and
committed medical device distributors, like Aspironix partnering with
Truscreen to bring our Truscreen cervical cancer screening technology to the
millions of women who are currently not covered by effective cervical cancer
screening."

All third world countries, ask yourself why is that ?